Extrapulmonary, Chronic Septic Arthritis From Mycobacterium tuberculosis in the Ankle and Subtalar Joints

J Am Acad Orthop Surg Glob Res Rev. 2024 Mar 11;8(3):e23.00273. doi: 10.5435/JAAOSGlobal-D-23-00273. eCollection 2024 Mar 1.

Abstract

In the United States, rates of Mycobacterium tuberculosis infection have been declining for decades. Osteoarticular tuberculosis of the ankle is rarely observed. We present the case of a 65-year-old man who immigrated to the United States from India 24 years before the onset of symptoms. The patient initially reported atraumatic swelling and pain of the left ankle and foot and was treated for venous insufficiency. Later, the patient was referred to a nonsurgical orthopaedic clinic for additional workup and was found to have elevated inflammatory markers. MRI showed septic arthritis and osteomyelitis of the talus, distal tibia, and calcaneus. Joint aspiration revealed elevated white blood cell counts with predominately PMNs. The patient was then referred to an orthopaedic foot and ankle surgeon and underwent extensive irrigation and débridement. The patient was discharged on empiric antibiotics. Culture results from the original joint aspirate returned 14 days after surgery as positive for acid-fast bacillus, later identified as M tuberculosis by sequencing. Empiric antibiotics were discontinued, and the patient was started on appropriate antituberculotic therapy. This case report illustrates the challenge in the diagnosis of skeletal tuberculosis and the importance of including this condition on the differential for patients with atypical foot and ankle presentations.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Ankle
  • Anti-Bacterial Agents / therapeutic use
  • Arthritis, Infectious* / diagnosis
  • Arthritis, Infectious* / drug therapy
  • Arthritis, Infectious* / surgery
  • Humans
  • Male
  • Mycobacterium tuberculosis*
  • Subtalar Joint*
  • Tuberculosis, Osteoarticular* / diagnostic imaging
  • Tuberculosis, Osteoarticular* / drug therapy

Substances

  • Anti-Bacterial Agents